Breaking News

Vetter’s Rankweil Site Receives Permanent Manufacturer’s Authorization

Austrian site supports manufacturing and quality control of Human Investigational Medicinal Products.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Vetter, a global CDMO, has received the permanent Manufacturer’s Authorization for its clinical development site in Rankweil, Austria. Operational for nearly two years, the responsible national regulatory authority, the Austrian Agency for Health and Food Safety (AGES) again inspected the site for issuance of a permanent Manufacturer’s Authorization. Prior to commissioning the site, the authority had carried out an initial inspection at the end of 2021, which resulted in a temporary Manufacturer...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters